Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$295M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$220M |
| 3 |
M&T Bank
MTB
|
+$207M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$190M |
| 5 |
Qualcomm
QCOM
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$324M |
| 2 |
Omnicom Group
OMC
|
+$321M |
| 3 |
VALE.P
Vale S A
VALE.P
|
+$266M |
| 4 |
America Movil
AMX
|
+$173M |
| 5 |
Apple
AAPL
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 25.32% |
| 2 | Communication Services | 22.94% |
| 3 | Financials | 10.81% |
| 4 | Healthcare | 9.59% |
| 5 | Technology | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VAR
151
DELISTED
Varian Medical Systems, Inc.
VAR
| $4.79M | 0.01% |
+73,070
| New | +$4.63M |
|
152
American Express
AXP
$233B
| $4.59M | 0.01% |
+60,810
| New | +$4.57M |
|
153
Nordson
NDSN
$16.9B
| $4.48M | 0.01% |
+60,859
| New | +$4.38M |
|
|
PACT
154
DELISTED
PACTERA TECHNOLOGY INTL LTD SPONSORED ADR
PACT
| $3.84M | 0.01% |
651,400
| – | – |
|
155
iShares MSCI ACWI ETF
ACWI
$32.8B
| $3.77M | 0.01% |
+70,000
| New | +$3.68M |
|
156
C.H. Robinson
CHRW
$17.2B
| $3.73M | 0.01% |
+62,687
| New | +$3.68M |
|
157
Johnson Controls International
JCI
$88.7B
| $3.73M | 0.01% |
+85,930
| New | +$3.64M |
|
158
iShares MSCI Brazil ETF
EWZ
$9.22B
| $3.26M | 0.01% |
68,011
-769
| -1% | -$34.2K |
|
159
MarketAxess Holdings
MKTX
$5.71B
| $2.8M | 0.01% |
46,600
+27,600
| +145% | +$1.47M |
|
160
Teva Pharmaceuticals
TEVA
$40.2B
| $2.62M | 0.01% |
69,350
| – | – |
|
161
Berkshire Hathaway Class A
BRK.A
$1.1T
| $2.56M | 0.01% |
15
| – | – |
|
|
NVDQ
162
DELISTED
Novadaq Technologies Inc.
NVDQ
| $2.45M | 0.01% |
148,000
+117,000
| +377% | +$1.66M |
|
163
Microchip Technology
MCHP
$40.8B
| $2.1M | 0.01% |
+104,474
| New | +$2.07M |
|
164
DexCom
DXCM
$32.9B
| $1.86M | ﹤0.01% |
264,000
+144,000
| +120% | +$912K |
|
165
IPG Photonics
IPGP
$3.7B
| $1.8M | ﹤0.01% |
31,900
+17,600
| +123% | +$1.03M |
|
|
STMP
166
DELISTED
Stamps.com, Inc.
STMP
| $1.77M | ﹤0.01% |
38,600
+18,600
| +93% | +$779K |
|
167
EPAM Systems
EPAM
$5.6B
| $1.64M | ﹤0.01% |
47,500
+27,000
| +132% | +$831K |
|
168
AeroVironment
AVAV
$8.06B
| $1.15M | ﹤0.01% |
49,800
+27,000
| +118% | +$603K |
|
169
MakeMyTrip
MMYT
$5.81B
| $1.09M | ﹤0.01% |
+73,800
| New | +$1.02M |
|
|
AMAP
170
DELISTED
AUTONAVI HLDGS LTD SPON ADR (CYM)
AMAP
| $1.02M | ﹤0.01% |
68,400
+30,400
| +80% | +$413K |
|
|
FARO
171
DELISTED
Faro Technologies
FARO
| $1.01M | ﹤0.01% |
23,900
+12,000
| +101% | +$460K |
|
|
GIVN
172
DELISTED
GIVEN IMAGING LTD
GIVN
| $874K | ﹤0.01% |
45,441
+28,100
| +162% | +$472K |
|
173
Acacia Research
ACTG
$447M
| $842K | ﹤0.01% |
36,500
+6,000
| +20% | +$137K |
|
174
Power Integrations
POWI
$3.37B
| $839K | ﹤0.01% |
31,000
+14,000
| +82% | +$363K |
|
|
NPSP
175
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $801K | ﹤0.01% |
25,173
| – | – |
|
Similar funds
Baillie Gifford & Co's Q3 2013 Portfolio in Review
As of Q3 2013, Baillie Gifford & Co held 215 positions worth $39.5B, up 20% from $33B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Baillie Gifford & Co deployed $1.19B of net new capital in Q3 2013, opening 28 new positions and adding to 101 existing holdings. Its largest new stake was Qualcomm: 2,456,400 shares worth $165M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 25% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Baidu, an estimated $324M trimmed.
- Baillie Gifford & Co's largest Q3 2013 buy was Qualcomm: 2,456,400 shares worth $165M.
- Baillie Gifford & Co added most to Tesla in Q3 2013, an estimated $295M increase.
- Baillie Gifford & Co's biggest Q3 2013 reduction was Baidu, cutting an estimated $324M.
- Baillie Gifford & Co fully exited Vale in Q3 2013, selling an estimated $19.6M.
- Baillie Gifford & Co's ten largest holdings make up 46% of its $39.5B portfolio in Q3 2013.
- Baillie Gifford & Co opened 28 new positions and closed 6 in Q3 2013.
- Baillie Gifford & Co's portfolio value rose 20% quarter-over-quarter to $39.5B.
Based on Baillie Gifford & Co's 13F filing for Q3 2013, filed 8 Nov 2013.